InspireMD (NSPR) Cost of Revenue (2010 - 2025)

InspireMD's Cost of Revenue history runs 16 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• On a quarterly basis, Cost of Revenue rose 33.04% year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $6.3 million, a 15.03% increase from a year earlier, with the FY2025 full-year figure at $6.3 million, up 15.03% from the prior year.
• Cost of Revenue improved to $2.0 million in Q4 2025 per NSPR's latest filing, from $1.7 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.0 million in Q4 2025 and bottomed at $776000.0 in Q2 2021.
• The 5-year median for Cost of Revenue is $1.1 million (2023), against an average of $1.2 million.
• Across the five-year window, Cost of Revenue jumped 98.18% in 2021 and dropped 23.76% in 2022, its largest moves.
• Year by year, Cost of Revenue stood at $1.1 million in 2021, then dropped by 23.76% to $828000.0 in 2022, then jumped by 51.69% to $1.3 million in 2023, then grew by 17.83% to $1.5 million in 2024, then surged by 33.04% to $2.0 million in 2025.
• Per Business Quant, the three latest NSPR Cost of Revenue figures stand at $2.0 million (Q4 2025), $1.7 million (Q3 2025), and $1.5 million (Q2 2025).